Geneva, 2 December 2016 – On 29 November 2016, Thomas B. Cueni was appointed Director General of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the organization representing biopharmaceutical companies as well as national and regional associations across the world. He will succeed Eduardo Pisani who recently announced his departure after seven years at the helm of IFPMA.

Thomas B. Cueni will leave his role as General Secretary and General Manager of Interpharma (www.interpharma.ch ), positions he has held for 28 years. He will take up his new appointment as Director General of IFPMA on 1st February 2017.

About IFPMA

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

Contact 

Morgane De Pol │Manager, Communications and Public Affairs │Tel:    +41 22 338 32 20 │

Mobile : +41 79 962 11 95 │ m.depol@ifpma.org │Twitter : @MorganePol

About IFPMA

IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.

To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.

ifpma.org

Media Contact

Elliot Dunster e.dunster@ifpma.org